These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 9337826)

  • 1. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ; Clark DJ; McFarlane LC
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ; Lipworth BJ
    Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
    Clark DJ; Clark RA; Lipworth BJ
    Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
    Wilson AM; Clark DJ; Devlin MM; McFarlane LC; Lipworth BJ
    Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
    Clark DJ; Grove A; Cargill RI; Lipworth BJ
    Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment.
    Wilson AM; Sims EJ; Lipworth BJ
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):329-35. PubMed ID: 10435058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
    Wilson AM; Clark DJ; McFarlane L; Lipworth BJ
    Eur J Clin Pharmacol; 1997; 53(1):33-7. PubMed ID: 9349927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
    Wilson AM; Lipworth BJ
    Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
    Wilson AM; McFarlane LC; Lipworth BJ
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
    Harrison TW; Wisniewski A; Honour J; Tattersfield AE
    Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
    Dempsey OJ; Wilson AM; Coutie WJ; Lipworth BJ
    Chest; 1999 Oct; 116(4):935-40. PubMed ID: 10531156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
    Lee DK; Bates CE; Currie GP; Cowan LM; McFarlane LC; Lipworth BJ
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
    Barnes NC; Hallett C; Harris TA
    Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal function and high dose inhaled corticosteroids for asthma.
    Yiallouros PK; Milner AD; Conway E; Honour JW
    Arch Dis Child; 1997 May; 76(5):405-10. PubMed ID: 9196354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
    Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Lönnebo A; Johansson M; Eckernäs SA
    Eur J Clin Pharmacol; 1997; 52(4):261-7. PubMed ID: 9248762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R
    Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
    Agertoft L; Pedersen S
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers.
    Dempsey OJ; Humphreys M; Coutie WJ; Lipworth BJ
    Eur J Clin Pharmacol; 2001 Nov; 57(9):637-41. PubMed ID: 11791892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.